advertisement
11.8 Neuroprotection (7)
Showing records 1 to 7
Display all abstracts in classification 11.8 Neuroprotection
Search within classification 11.8 Neuroprotection15334 Nitric oxide mediates excitotoxic and anoxic damage in rat retinal ganglion cells cocultured with astroglia
Morgan J; Caprioli J; Koseki Y
Archives of Ophthalmology 1999; 117: 1524-1529
15513 Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina
Osborne NN; DeSantis L; Bae JH; Ugarte M; Wood JPM; Nash MS; Chidlow G
Experimental Eye Research 1999; 69: 331-342
15539 Glaucomatous neurodegeneration and the concept of neuroprotection
Bautista RD
International Ophthalmology Clinics 1999; 39: 57-70
15540 Saving the nerve from glaucoma: memantine to caspaces
Naskar R; Vorwerkd CK; Dreyer EB
Seminars in Ophthalmology 1999; 14: 152-158
15541 Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma
Neufeld AH; Sawada A; Becker B
Proceedings of the National Academy of Sciences of the United States of America 1999; 96: 9944-9948
15542 Effects of nicergoline on the retinal and cortical electrophysiological responses in glaucoma patients: a preliminary open study
Parisi V; Colacino G; Milazzo G; Scuderi AC; Manni G
Pharmacological Research 1999; 40: 249-255
15543 Is neuroprotection a viable therapy for glaucoma?
Weinreb RN; Levin LA
Archives of Ophthalmology 1999; 117: 1540-1544
